Back to dashboard
CommercialCoverageMedium impact

Focal Treatments for Prostate Cancer

Blue Cross & Blue Shield of Mississippi·MS · Urology, Oncology·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

BCBS Mississippi has updated their medical policy for focal treatments for prostate cancer, maintaining that all focal therapy modalities (including focal laser ablation, HIFU, cryoablation, radiofrequency ablation, photodynamic therapy, and irreversible electroporation) remain investigational and are not covered. The policy provides updated device information and FDA clearances but does not change the coverage determination.

Action Required

Action needed
Billing team should verify that claims for focal prostate cancer treatments using CPT codes 55899, 55880, and 0655T continue to be flagged as investigational/non-covered for BCBS Mississippi members. Ensure providers are aware that these procedures remain non-covered despite updated device information in the policy.

Affected Billing Codes

55899
55880